AMPHADASE is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amphastar Pharmaceuticals, Inc.. The primary component is Hyaluronidase.
| Product ID | 0548-9090_9d798dca-17f4-4ab4-9c1e-7d6f4f1bfa40 |
| NDC | 0548-9090 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AMPHADASE |
| Generic Name | Hyaluronidase |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2004-10-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021665 |
| Labeler Name | Amphastar Pharmaceuticals, Inc. |
| Substance Name | HYALURONIDASE |
| Active Ingredient Strength | 150 [USP'U]/mL |
| Pharm Classes | Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2004-10-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021665 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2004-10-26 |
| Marketing Category | NDA |
| Application Number | NDA021665 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2004-10-26 |
| Marketing End Date | 2014-05-16 |
| Ingredient | Strength |
|---|---|
| HYALURONIDASE | 150 [USP'U]/mL |
| SPL SET ID: | 8396ea96-7cb5-4e26-87a4-90bca9c3c6dd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0548-9090 | AMPHADASE | hyaluronidase |
| 51662-1555 | HYALURONIDASE | HYALURONIDASE |
| 17478-560 | Hydase | Hyaluronidase |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AMPHADASE 76632115 3057031 Live/Registered |
Amphastar Pharmaceuticals, Inc. 2005-02-25 |